RNA interference: a potential strategy for isoform-specific phosphatidylinositol 3-kinase targeted therapy in ovarian cancer.

Détails

ID Serval
serval:BIB_71D713DE929E
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
RNA interference: a potential strategy for isoform-specific phosphatidylinositol 3-kinase targeted therapy in ovarian cancer.
Périodique
Cancer Biology and Therapy
Auteur⸱e⸱s
Zhang L., Yang N., Liang S., Barchetti A., Vezzani C., Huang J., O'Brien-Jenkins A., Rubin S.C., Coukos G.
ISSN
1538-4047 (Print)
ISSN-L
1538-4047
Statut éditorial
Publié
Date de publication
2004
Volume
3
Numéro
12
Pages
1283-1289
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov'tPublication Status: ppublish
Résumé
Phosphatidylinositol 3-kinase (PI3-kinase) is a novel intracellular transducer involved in a wide range of cancer-associated signaling pathways, which comprises various isoforms and splice variants with distinct biologic activities and clinical implications. Especially, the class Ia PI3-kinase 110 kD catalytic subunit alpha (PIK3CA) is the most important isoform in tumorigenesis and possibly, tumor angiogenesis. Several strategies have been developed to block PI3-kinase for cancer therapy; however, the approach to target specific PI3-kinase isoform has not been explored to date. In the present study, we show that RNA interference (RNAi) through small interfering (siRNA) sequences targeting PIK3CA has potential applications in isoform-specific "knock-down" of PI3-kinase. This strategy provides a novel tool to study the function of various PI3-kinase isoforms and may contribute to isoform-specific targeting of PI3-kinase in human cancer.
Mots-clé
Animals, Blotting, Western, Cell Proliferation, Female, Genetic Vectors, Humans, Mice, Ovarian Neoplasms/genetics, Ovarian Neoplasms/metabolism, Phosphatidylinositol 3-Kinases/antagonists & inhibitors, Phosphatidylinositol 3-Kinases/genetics, Protein Isoforms, RNA Interference, RNA, Small Interfering/pharmacology, Tumor Cells, Cultured, Tumor Markers, Biological/metabolism
Pubmed
Web of science
Création de la notice
14/10/2014 12:43
Dernière modification de la notice
20/08/2019 15:30
Données d'usage